Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection

Emerg Infect Dis. 2022 Feb;28(2):411-414. doi: 10.3201/eid2802.211938. Epub 2021 Dec 1.


Ten days after receiving the first dose of coronavirus disease vaccine, a 22-year-old woman in South Korea experienced myocarditis, myopathy, pericarditis, and gastroenteritis; rash subsequently developed. There was no evidence of prior infection with severe acute respiratory syndrome coronavirus 2. The diagnosis was multisystem inflammatory syndrome resulting from coronavirus disease vaccination.

Keywords: 2019 novel coronavirus disease; COVID-19; ChAdOx1 nCoV-19 vaccine; MIS-A; SARS-CoV-2; anti-S receptor-binding protein antibody; atrial fibrillation; coronavirus disease; multisystem inflammatory syndrome; myopathy; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine-related adverse events; viruses; zoonoses.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • COVID-19 Vaccines
  • COVID-19*
  • Female
  • Humans
  • Republic of Korea
  • SARS-CoV-2
  • Vaccination
  • Young Adult


  • COVID-19 Vaccines